中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
7期
255-256
,共2页
步长脑心通%脑血栓%血塞通
步長腦心通%腦血栓%血塞通
보장뇌심통%뇌혈전%혈새통
Buchang naoxintong%Thrombosis%Xuesaitong
目的:探讨步长脑心通治疗脑血栓的临床效果研究。方法选取2013年9月~2014年11月我院接诊的36例脑血栓患者,按照入院的先后顺序分为两组,实验组和对照组,实验组给予步长脑心通,对照组给予纳洛酮,观察两组患者的治疗效果。结果实验组患者的治疗总有效率高于对照组,差异有统计学意义(P<0.05);实验组患者的药物起效时间、神经功能缺损程度评分低于对照组,差异有统计学意义(P<0.05)。结论步长脑心通治疗脑血栓的效果显著,治疗的总有效率高,药物起效时间快,对神经功能的缺损程度低。
目的:探討步長腦心通治療腦血栓的臨床效果研究。方法選取2013年9月~2014年11月我院接診的36例腦血栓患者,按照入院的先後順序分為兩組,實驗組和對照組,實驗組給予步長腦心通,對照組給予納洛酮,觀察兩組患者的治療效果。結果實驗組患者的治療總有效率高于對照組,差異有統計學意義(P<0.05);實驗組患者的藥物起效時間、神經功能缺損程度評分低于對照組,差異有統計學意義(P<0.05)。結論步長腦心通治療腦血栓的效果顯著,治療的總有效率高,藥物起效時間快,對神經功能的缺損程度低。
목적:탐토보장뇌심통치료뇌혈전적림상효과연구。방법선취2013년9월~2014년11월아원접진적36례뇌혈전환자,안조입원적선후순서분위량조,실험조화대조조,실험조급여보장뇌심통,대조조급여납락동,관찰량조환자적치료효과。결과실험조환자적치료총유효솔고우대조조,차이유통계학의의(P<0.05);실험조환자적약물기효시간、신경공능결손정도평분저우대조조,차이유통계학의의(P<0.05)。결론보장뇌심통치료뇌혈전적효과현저,치료적총유효솔고,약물기효시간쾌,대신경공능적결손정도저。
Objective To explore the clinical efficacy of buchang naoxintong medicine in treatment of thrombosis. Methods 36 thrombosis patients were collected from September 2013 to November 2014 in our hospital, and were divided into study group and control group according to their hospitalization sequence. Patients in the study group were given buchang naoxintong medicine treatment, while, patients in control group were given Naloxone treatment. Then observed and compared the treatment efficacy of the two groups. Results The total effective rate in the study group was much higher than control group, and the difference between two groups was significant(P<0.05). Besides, the medicine take-effect time and nerve function damage degree of patients in the study group were much lower than control group, and the difference between two groups was significant too(P<0.05). Conclusion Buchang naoxintong medicine in treatment of thrombosis has remarkable efficiency and highly total rate of clinical efficacy. It has quick medicine take-effect time and less nerve function damage. Thus, it is worthy to be clinically promoted.